Azin Parhizgar, PhD, President and Chief Executive Officer
Dr. Parhizgar is an experienced and successful medical device industry executive and entrepreneur. Prior to joining Claret Medical, she served as the Chief Operating Officer of Conor Medsystems which led to the acquisition of the company by Johnson & Johnson, Inc. in 2007. She spent one year post-merger with Johnson & Johnson for full integration of the companies. Between 1996-2000 she held the positon of Executive Vice President for Arterial Vascular Engineering, which was acquired by Medtronic. She spent two years at Medtronic post-merger in increasing roles of responsibility leading to her role as Executive Vice President of Emerging Ventures and New Technologies. Dr. Parhizgar has served as an advisor to emerging medical device technology companies including several Board of Directors and Scientific Advisory Board positions. Dr. Parhizgar received both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University, Providence, RI.
Tony Fields, Chief Operating Officer
Mr. Fields joined Claret Medical as Vice President of Engineering and Operations in August 2011 prior to being promoted to Chief Operating Officer in August of 2012. Prior to Claret, Tony served for two years as the Vice President of Research and Development and Operations for Voyage Medical, managing the development of an image-guided cardiac ablation catheter and system to treat complex arrhythmias. For over eight years prior to Voyage Medical, Tony was the first employee and Vice President of Research and Development for Emphasys Medical, a startup focused on developing a one-way valve mounted on a self-expanding stent for implantation in the airways of the lung to treat emphysema. Prior to Emphasys, Tony spent over two years as the Vice President of Engineering at Reconstructive Technologies, a startup attempting to grow human skin in vitro, and eight years at IDEO Product Development managing numerous consulting projects in medical devices from infusion pumps to clinical lab instrumentation to drug delivery systems. Tony holds a B.S. in Mechanical Engineering from U.C. Berkeley, a M.S. in Mechanical Engineering from M.I.T., and a M.Sc. in Electrical Engineering from Imperial College in London.
Jon Bohane, Chief Financial Officer
Mr. Bohane is an experienced Chief Financial Officer with an expertise in financial management and accounting for emerging and fast-growth companies in the interventional cardiology space. In his more than 20 years of experience, his CFO roles have included not only Claret Medical, but also Cibiem (catheter-based Carotid Body Modulation), Velomedix (therapeutic hypothermia for heart attack and stroke), Sadra Medical (transcatheter aortic valve replacement) and SquareOne, Inc. (aorto-ostial stents). In this time, he has organized companies financially and administratively from inception to commercialization, secured numerous rounds of growth capital, and overseen acquisition. He has also served as Vice President, Finance and Administration for AccessClosure, a vascular closure company, and as Director of Finance and Administration at Embolic Protection, Inc., a distal protection company, which was acquired by Boston Scientific during his tenure. He holds a Bachelor of Science degree in Business with an emphasis in Finance and Economics from San Jose State University.
James Hallums, Chief Commercial Officer
Mr. Hallums has worked in the cardiovascular medical device space for the last 20 years. James joined Claret Medical in October of 2013 as International General Manager and Sr. Vice President, responsible for all International commercial and downstream therapy development activities including distributor management, physician training, clinical support and reimbursement. After Claret Medical received FDA approval in June 2017, James relocated from Belgium to the U.S. as a result of expanded responsibilities for U.S. launch of the Sentinel Cerebral Protection System (CPS). Prior to Claret Medical, he worked at St. Jude Medical where he was the Senior International Marketing Director responsible for the Portico™ TAVR, the EnligHTN™ Renal denervation and their internal Percutaneous Mitral Valve Repair programs. Mr. Hallums has also held multiple Director positions in companies such as Conor Medsystems and Cordis cardiology, both in the field of Drug Eluting Stents. Prior to that, he worked for both Medtronic AVE and Guidant in the Neurovascular Stroke business units in clinical and regulatory management positions.
Daniel Fifer, Vice President, Research and Development
Dan Fifer was part of the initial staffing of Claret Medical and has been responsible for the product development effort, contributing to design, intellectual property, and physician training. He has spent time with the scientific advisory board and time in the field in support of training and clinical cases. Prior to Claret Medical, Dan served as a principal engineer at Synecor, LLC, an incubator which starts new medical device companies. Previously, he served as an engineer at Bioheart, Inc., a start-up company that developed a novel therapy for treatment of myocardial infarction. Dan was instrumental in the FDA investigational device approval process and attended the first U.S. clinical cases. Prior to Bioheart, he was a project engineer and manager at AVE (Medtronic), where he led the development of new stent delivery platforms through successful commercial launch. Dan started his engineering career in process development at Applied Medical Resources, where he was responsible for the transfer of products from research and development to manufacturing. He holds two Bachelor’s degrees from the University of California, Davis in Biological Systems Engineering and Physiology.
Brian Cleary, Vice President of Clinical and Regulatory Affairs
Mr. Cleary joined Claret Medical in November of 2017 and brings 25 years of clinical affairs, quality assurance and regulatory affairs experience spanning a broad range of medical device technologies. Prior to embarking on a successful consulting career, Brian held management positions at various companies, including Hayes Medical (now Consensus Orthopedics), Arterial Vascular Engineering (acquired by Medtronic), EKOS Corporation (acquired by BTG), Northstar Neuroscience (IPO) and Pathway Medical (acquired by Bayer Healthcare). Throughout his career, Brian has had extensive success in regulatory strategy development and execution, including multiple US FDA 510(k) clearances, as well as IDE, PMA and CE Mark approvals. Brian is a graduate of UC Davis and holds a Bachelor’s degree in Applied Mathematics and a Master’s degree in Statistics.
Lou Molinari, Vice President of Operations
Mr. Molinari brings over 30 years of experience in Operations, Manufacturing, and Engineering Management to Claret Medical. He Joined Claret Medical in July 2015. His experiences have taken him through several industries, which include medical devices, semiconductor equipment, telecommunications components, disk drive manufacturing, and power generation. Prior to Claret Medical, he held the position of VP of Operations for 7 years at TriVascular, a medical device company focusing on Aortic Aneurism repair. He held this position from early startup product development, FDA approval, commercialization and an IPO. Lou also held the position of Director of Manufacturing/Process Development Engineering for TriVascular as well as Boston Scientific. Lou holds bachelor’s degrees in Electrical Engineering from California Polytechnic University, San Luis Obispo.